Cited 0 time in
Prolonged tyrosine kinase activation of insulin receptor by pY27-caveolin-2
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kwon, Hayeong | - |
| dc.contributor.author | Pak, Yunbae | - |
| dc.date.accessioned | 2022-12-27T04:21:36Z | - |
| dc.date.available | 2022-12-27T04:21:36Z | - |
| dc.date.issued | 2010-01-01 | - |
| dc.identifier.issn | 0006-291X | - |
| dc.identifier.issn | 1090-2104 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/25258 | - |
| dc.description.abstract | Caveolin-2 regulation of insulin receptor (IR) tyrosine kinase activity was investigated. An insulin time course revealed that rapidly induced tylosine phosphorylation of IR was steadily maintained over a 180 min time period. In parallel, insulin-exerted IR interaction with caveolin-2 was detected as early as 5 min throughout until 180 min. Down-regulation of caveolin-2 by caveolin-2 siRNA arrested specifically a long term activation of IR. The attenuation of IR activation resulted in retardation of rapamycinsensitive pS727-STAT3 activation. As caveolin-2 tyrosine mutants were examined, Y27A-caveolin-2 explicitly impeded the long term IR activation by insulin, enhanced tyrosine dephosphorylation of IR, impaired tyrosine phosphorylation of IRS-1. and exerted the interaction between activated IR and SOCS-3 To.-ether. we propose that pY27-caveolin-2 prolongs IR activation by its interaction with IR, thereby preventing IR interaction with SOCS-3. (C) 2009 Elsevier Inc All rights reserved | - |
| dc.format.extent | 7 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE | - |
| dc.title | Prolonged tyrosine kinase activation of insulin receptor by pY27-caveolin-2 | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1016/j.bbrc.2009.10.159 | - |
| dc.identifier.wosid | 000273624500010 | - |
| dc.identifier.bibliographicCitation | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, v.391, no.1, pp 49 - 55 | - |
| dc.citation.title | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | - |
| dc.citation.volume | 391 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 49 | - |
| dc.citation.endPage | 55 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
| dc.relation.journalResearchArea | Biophysics | - |
| dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
| dc.relation.journalWebOfScienceCategory | Biophysics | - |
| dc.subject.keywordPlus | SERINE PHOSPHORYLATION | - |
| dc.subject.keywordPlus | GENE-EXPRESSION | - |
| dc.subject.keywordPlus | ADIPOSE-TISSUE | - |
| dc.subject.keywordPlus | CELL-LINES | - |
| dc.subject.keywordPlus | CPG ISLAND | - |
| dc.subject.keywordPlus | RESISTANCE | - |
| dc.subject.keywordPlus | CAVEOLIN-1 | - |
| dc.subject.keywordPlus | SOCS-3 | - |
| dc.subject.keywordPlus | CARCINOMA | - |
| dc.subject.keywordPlus | PROTEINS | - |
| dc.subject.keywordAuthor | pY27-caveolin-2 | - |
| dc.subject.keywordAuthor | Insulin receptor | - |
| dc.subject.keywordAuthor | PTPs | - |
| dc.subject.keywordAuthor | SOCS-3 | - |
| dc.subject.keywordAuthor | IRS-1 | - |
| dc.subject.keywordAuthor | Rapamycin | - |
| dc.subject.keywordAuthor | pS727-STAT3 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
